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Background: Peroxiredoxin V (Prdx V) plays a major role in preventing oxidative damage as an effective antioxidant
protein within a variety of cells through peroxidase activity. However, the function of Prdx V is not limited to
peroxidase enzymatic activity per se. It appears to have unique function in regulating cellular response to external
stimuli by directing interaction with signaling protein. In this study, we identified Prdx V interacting partners in
mouse kidney under hypoxic stress using immunoprecipitation and shotgun proteomic analysis (LC-MS/MS).
Results: Immunoprecipitation coupled with nano-UPLC-MSE shotgun proteomics was employed to identify putative
interacting partners of Prdx V in mouse kidney in the setting of hypoxia. A total of 17 proteins were identified as
potential interacting partners of Prdx V by a comparative interactomics analysis in kidney under normoxia versus
hypoxia. Dihydrolipoamide branched chain transacylase E2 (DBT) appeared to be a prominent candidate protein
displaying enhanced interaction with Prdx V under hypoxic stress. Moreover, hypoxic kidney exhibited altered DBT
enzymatic activity compared to normoxia. An enhanced colocalization of these two proteins under hypoxic stress
was successfully observed in vitro. Furthermore, peroxidatic cysteine residue (Cys48) of Prdx V is likely to be responsible
for interacting with DBT.
Conclusions: We identified several proteins interacting with Prdx V under hypoxic condition known to induce renal
oxidative stress. In hypoxic condition, we observed an enhanced interaction of Prdx V and DBT protein as well as
increased DBT enzymatic activity. The results from this study will contribute to enhance our understanding of Prdx V’s
role in hypoxic stress and may suggest new directions for future research.
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Peroxiredoxins (Prdxs) are known to include six iso-
forms with different cellular localizations, and constitute
0.1–1% of total soluble protein in most human cells [1].
Prdxs play major roles in preventing oxidative damage
as the effective antioxidant proteins within a variety of
cells through peroxidase activity [2]. In mammalian* Correspondence: thlee83@chonnam.ac.kr
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unless otherwise stated.cells, Prdx V was identified originally as a transcrip-
tional corepressor [3], and a peroxisomal and mito-
chondrial antioxidant protein [4]. Recently, Prdx V was
found to be a stress-inducible factor under specialized
oxidative stress conditions, especially hypoxic stress
[5]. This protein appears to be multifunctional, and the
full spectrum of cellular functions of Prdx V remains
unknown.
Hypoxia is one of the most important factors influen-
cing clinical outcomes in the renal environment [6]. A
growing body of literature has implicated hypoxia in the
pathogenesis of both acute and chronic renal disease
[7-9]. The partial pressure of oxygen (pO2) in the kidney
is ordinarily sustained at well-balanced levels by complexis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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filtration rate, O2 consumption, and arteriovenous O2
shunting [10]. Kidney is particularly susceptible to hypoxic
damage depending on the delicacy of these complex func-
tional interactions. Renal cells use various molecular path-
ways that allow them to respond and adapt to changes in
renal oxygenation [11]. The efficient metabolic acclima-
tion to low pO2 is thus a vital factor for maintenance of
renal transport ability and essential for cell survival. For
example, the prolyl-4-hydroxylase domain (PHD)/hyp-
oxia-inducible factor (HIF) pathway has a primal role in
metabolic reprogramming under low pO2 conditions so
that it regulates cellular energy and glucose metabolism at
multiple levels. HIFs alter metabolic conditions from oxi-
dative phosphorylation to anaerobic glycolysis, and inhibit
mitochondrial respiration and ROS generation. It does
this by increasing the expression of glycolytic enzymes,
by blocking the conversion of pyruvate to acetyl CoA
through transcriptional upregulation of pyruvate de-
hydrogenase kinase, and by regulating the expression of
proteins that compose the mitochondrial respiratory
chain [11]. Also, mitochondrial biogenesis and its con-
sequent processes enhance metabolic pathways such as
fatty acid oxidation and boost antioxidant defense
mechanisms that remediate injury from tissue hypoxia,
and glucose or fatty acid overburden, all of which would
otherwise contribute to the pathogenesis of acute and
chronic kidney disease [12].
Our previous study indicated that Prdx V exerted pro-
tective effects in the hypoxic kidney by regulating a var-
iety of individual proteins in a protein network. Using
shotgun proteomic analysis, it has been shown that
knocking down Prdx V influences the expression of a
variety of protein groups associated with oxidative stress,
mitochondrial transport, fatty acid metabolism, amino
acid/nucleic acid metabolism, glycolysis/gluconeogene-
sis, and the cytoskeleton. Additionally, the hypoxic kid-
neys in Prdx V knock-down mice (Prdx Vsi) showed
insufficient activities of mitochondrial metabolic enzymes,
especially aconitase 2 (Aco2), acyl-CoA dehydrogenase
C-4 to C-12 straight chain (Acadm), and acyl-CoA oxi-
dase 1 (Acox1) [13]. Taken together, these findings sug-
gest that Prdx V may be involved in the coupling of a
broad range of cellular signaling cascades to maintain
renal homeostasis under hypoxic conditions. To gain
further insights into the mechanisms regulated by Prdx
V in hypoxic conditions, we employed an approach to
compare the interacting partners in the kidneys under
normoxia versus hypoxia. Here, we report Prdx V inter-
actome using a strategy of immunoprecipitating Prdx
V-protein complexes in the hypoxic kidney. Our data
reveal a promising target protein interacting with Prdx
V in the hypoxic kidney and provide a potential thera-
peutic target for chronic kidney disease.Results
Identification of Prdx V interactome in normoxic and
hypoxic mouse kidney
Previously, we reported that Prdx V was a novel regula-
tor of renal homeostasis under hypoxic stress, altering
protein networks associated with oxidative stress, fatty
acid metabolism, and mitochondrial dysfunction [13]. How-
ever, it is still unclear which protein/molecules interact with
Prdx V in regulating kidney homeostasis. To capture
potential interaction partners of mouse Prdx V, we used
an anti-Prdx V antibody to immunoprecipitate Prdx V
and its interacting proteins from normoxic and hypoxic
kidneys. The immunoprecipitates were then subjected
to gel-assisted digestion followed by nano-UPLC-MS
analysis. According to Han et al., to maximize protein
digestion efficiency and recovery (>90%) [14], we employed
the gel-assisted digestion method. We next subjected the
digested protein to a nano-UPLC-MSE proteomic analysis
to identify proteins interacting with Prdx V. We compared
the proteomic data from three independent experiments
to determine meaningful targets with high reproducibility.
In detail, 27 (149 spectra) and 33 (276 spectra) proteins
were identified as Prdx V’s interaction proteins under
normoxic and hypoxic conditions, respectively. Table 1
summarizes the potential interacting partners of Prdx V,
identified under normoxic and hypoxic conditions.
Among them, 13 proteins showed increased interaction
with Prdx V in the hypoxic versus the normoxic kidney:
Rab43, DBT, Alb, Pcca, Krt76, Krt14, Krt17, Krt84,
Krt72, Krt74, Krt77, Krt42, and Pccb. On the other
hand, four proteins showed decreased interaction with
Prdx V in the hypoxic versus the normoxic kidney:
Gba2, Txn1, Krt78, and Krt32 (Table 1).
To confirm our proteomics analysis for identifying
Prdx V interaction partners, coprecipitation experiments
were performed, targeting some representative proteins.
As shown in Additional file 1: Figure S1, Rab43, Alb,
and Pccb were shown to strongly coprecipitate with
Prdx V in hypoxia, consistent with the proteomics ana-
lysis in Table 1. Taken together, these findings suggest
that Prdx V could act as a direct regulator in hypoxia
and be involved in maintaining kidney homeostasis.
Interaction of Prdx V and DBT in hypoxic mouse kidney
Of the Prdx V-interacting proteins, DBT appeared to be
an interesting target. As shown in Table 1, DBT was
identified two of three times in hypoxia, whereas it was
not detected in normoxia. In our previous study, DBT
protein appeared to be associated with Prdx V in hypoxic
stress [13]. DBT is known as a transacylase component of
the mitochondrial multienzyme BCKDH complex and it
regulates branched-chain amino acid (BCCA) degradation.
This raises the questions as to whether hypoxia enhances
the Prdx V-DBT interaction and/or influences DBT
Table 1 Protein showing altered interaction by Prdx V immunoprecipitation during hypoxic stressa




IPI00130467 Ras related protein Rab 43 isoform b Rab43 228.7 6 ND 1/3
IPI00130535 Lipoamide acyltransferase component of branched chain
α-keto acid dehydrogenase complex, mitochondial
Dbt 302.6 8 ND 2/3
IPI00131695 Serum albumin Alb 325.3 3 1/3 3/3
IPI00225123 Non-lysosomal glucosylceramidase Gba2 191.4 9 1/3 ND
IPI00226993 Thioredoxin Txn1 1155.1 3 3/3 2/3
IPI00330523 Propionyl CoA carboxylase alpha chain, mitochondrial Pcca 474.0 21 2/3 3/3
IPI00346834 Keratin type II cytoskeletal 2, oral Krt76 184.2 7 ND 1/3
IPI00348328 Keratin Kb40 Krt78 580.5 19 1/3 ND
IPI00122281 Keratin type I cuticular Ha2 Krt32 260.3 8 1/3 ND
IPI00227140 Keratin type I cytoskeletal 14 Krt14 1399.7 16 ND 1/3
IPI00230365 Keratin type I cytoskeletal 17 Krt17 1322.1 16 ND 1/3
IPI00347019 Keratin type II cuticular Hb4 Krt84 330.8 10 ND 1/3
IPI00347096 Keratin type II cytoskeletal 72 Krt72 337.2 8 ND 1/3
IPI00420970 Keratin type II cytoskeletal 74 Krt74 1999.7 4 1/3 3/3
IPI00462140 Keratin type II cytoskeletal 1b Krt77 2014.2 7 ND 1/3
IPI00468696 Keratin type I cytoskeletal 42 Krt42 798.6 12 ND 1/3
IPI00606510 Propionyl CoA carboxylase beta chain, mitochondrial Pccb 266.6 10 2/3 3/3
aProteins were affinity-purified from mouse kidneys under both normoxic and hypoxic conditions as bound interactors with Prdx V immunoprecipitation. The
purified immunoprecipitates were applied to acrylamide gel-associated tryptic digestion and subjected to nano-UPLC-MS/MS for protein identification.
bFrequency represents the number of times that the interactors were observed in three independent experiments. ND, not detected.
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tein interaction using a reverse immunoprecipitation
(Figure 1A). As a result, we found a four-fold higher
interaction between Prdx V and DBT in hypoxia than
normoxia (Figure 1B). To our knowledge, this is the
first report showing that Prdx V could bind directly to
DBT and this interaction was enhanced by hypoxic
stress, which might suggest a strong linkage to amino
acid metabolism and oxidative stress.
To examine the effect of hypoxia on DBT enzymatic
activity, we assayed DBT enzymatic activities in mouse
kidneys under normoxic and hypoxic conditions. DBT
enzymatic activities in hypoxic and normoxic mouse kid-
neys were 1.20 ± 0.05 and 0.88 ± 0.04 mU/mg, respectively
(n = 10 mice for each group; Figure 2). This indicates that
hypoxic treatment resulted in a significant increase in
DBT activity (about 1.5-fold) versus normoxic conditions
(Figure 2, inset bar graph).
We next performed co-immunostaining of Prdx V and
DBT to determine their subcellular co-localization in
normoxic and hypoxic conditions. HEK293 cells were
cotransfected with a myc-tagged DBT and a HA-tagged
Prdx V. As shown in Figure 3, DBT (green) was coloca-
lized with Prdx V proteins (red) in hypoxic HEK293
cells, while the complex was weakly detectable in nor-
moxic cell. Colocalized pixels were quantified as the per-
centage of overlapping selected red (Prdx V) and greenpixels (DBT) and revealed that co-localization of these
proteins increased 3.8-fold in hypoxia versus normoxia
(Figure 3, inset bar graph).
Cysteine 48 of Prdx V is required for the interaction with
DBT
Human Prdx V has one catalytic cysteine residue, Cys
48, which is highly conserved in all other peroxiredoxins
(Prdx I-IV and VI), and this cysteine residue is involved
in Prdx V’s peroxidase activity [15]. Most recently, we
demonstrated that Prdx V interacts with Jak2 via the
catalytic Cys 48 to modulate the Jak2-Stat5 pathway
[16]. Based on our previous observations, we next asked
whether the catalytic Cys 48 plays a role in the Prdx
V-DBT interaction. To test this, we transiently co-
transfected HEK293 cells with a myc-tagged DBT and a
HA-tagged wild-type (WT) or a cysteine mutant Prdx V
(C48S, C73S, C152S, and C48/152S) expression construct.
Then, total cell lysate proteins from transfected-HEK293
cells under normoxia and hypoxia were used for immuno-
precipitations with anti-myc-conjugated agarose. The cel-
lular expression of DBT and PrdxV for each transfected
construct showed the same background for every Prdx V
mutant (Figure 4A). As shown in Figure 4B, WT Prdx V
bound weakly to DBT under normoxic conditions, but
this interaction showed a significant increase under hyp-
oxic stress. In the case of the Prdx V C152S mutant, the
Figure 1 Coprecipitation of endogenous Prdx V and DBT in normoxic and hypoxic mouse kidney. (A) Immunoprecipitates identified by
DBT from normoxic and hypoxic (H, lanes 3, 4) mouse kidney were probed with a Prdx V antibody (n = 5). (B) Histogram showing numerical data
obtained by densitometry analysis of (A). The histogram graph is expressed as mean values ± standard deviation (**p < 0.05). WCE, whole cell
lysate of mouse kidney.
Figure 2 In vitro activities of DBT enzyme in normoxic and hypoxic mouse kidneys. Plots show time-dependent changes in absorbance
at 340 nm. The histograms in the insets show the slopes (rate) of the changes in the linear portion of the curves. The y-axes in the histograms
indicate the specific activity expressed as mU/mg mitochondrial protein. 1 mU is defined as the amount of enzyme needed to reduce 1 nmol
of NAD+ per min at 37°C. Assays were carried out with the mitochondrial fraction of homogenized tissue extract, and the reactions were run
using sodium α-ketoisocaproate as the substrate. Data are expressed as mean values ± standard deviation (**p < 0.05). Open circles and histogram,
normoxia; closed circles and histogram, hypoxia.
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Figure 3 Co-localization of Prdx V and DBT in normoxic and hypoxic HEK293 cells. Confocal images of costaining with antibodies to Prdx V
and DBT. HEK293 cells were co-transfected with Prdx V- and DBT-expressing vectors, and then the transfected cells were exposed to hypoxic stress
(1 ± 0.2%) for 6 h. Cells were fixed on polylysine slides and stained with Prdx V (red) or DBT (green) antibodies.
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Prdx V. However, Prdx V C48S mutant and double mu-
tant (C48/152S) showed diminished interactions with
DBT under both normoxic and hypoxic conditions. This
result is consistent with our previous finding of the cyst-
eine 48 residue’s role in the interaction of Prdx V and
Jak2. Additionally, Prdx V C73S showed a notable increase
in the interaction with DBT in both normoxic and hyp-
oxic conditions. This needs further investigation. Using re-
verse immunoprecipitation, we also found that Prdx V and
DBT interaction was increased in hypoxia. Although Prdx
V 73S showed increased interaction with DBT, Prdx V
C48S showed decreased interaction with DBT (Figure 4C).
Thus, these data indicate that the Prdx V and DBT inter-
action during normoxic and hypoxic conditions requires
the catalytic cysteine of Prdx V.
Discussion
Prdx V has a remarkably wide subcellular distribution
compared with the other mammalian peroxiredoxins[17]. Although Prdx V appears to be constitutively and
ubiquitously expressed in most mammalian tissues, its
expression is also upregulated in various pathophysio-
logical situations in response to various stresses [15].
In this study, we employed a manageable and rapid
protocol by combining Prdx V immunoprecipitation and
shotgun proteomics (LC-MS/MS) to identify Prdx V and
its interacting proteins in the hypoxic mouse kidney.
Using this approach, we found several novel partners
interacting with Prdx V from three independent repli-
cates (Table 1). To confirm our proteomics analyses, co-
immunoprecipitations were conducted using anti-target
antibodies in normoxic and hypoxic mouse kidneys, and
our candidate targets were validated (data not shown).
Using functional annotation analysis, some Prdx V-
interacting partners, such as DBT, Pcca, and Pccb, ap-
peared to be related to various mitochondria-associated
metabolism functions. This is consistent with a previous
report regarding the targets in Prdx V knock-down
mouse kidney under hypoxia [13]. Of note, Prdx V
Figure 4 Comparative interactions of Prdx V WT or cysteine mutants with DBT in normoxic and hypoxic cells. (A) All WCE presented for
every Prdx V mutant showed the same background of cellular expression for each transfected construct. (B) Coprecipitation of HA-tagged Prdx V
with myc-tagged DBT. (C) Reverse immunoprecipitation of myc-tagged DBT with HA-tagged Prdx V. HEK293 cells were cotransfected with the
HA-tagged Prdx V WT or cysteine mutant (C48S, C73S, C152S, C48/152S) and myc-tagged DBT expression vector, and then incubated under normoxic
and hypoxic conditions. WCE, whole cell lysate of HEK293 cell; Mock, the empty vector tagged to myc or HA.
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under hypoxic stress by altering metabolism and causing
mitochondrial dysfunction.
The BCKDH complex is an inner-mitochondrial en-
zyme complex involved in the breakdown of BCAAs,
such as isoleucine, leucine, and valine, which is thought
to be composed of a core of 24 transacylase (E2) sub-
units, and associated with decarboxylase (E1), dehydro-
genase (E3), and regulatory subunits [18,19]. BCAAs are
essential amino acids that serve as substrates for protein
synthesis and also function in nutritional signals, regu-
lating carbohydrate metabolism, energy balance and hor-
mone secretion. Thus, the homeostasis of BCCAs is
tightly regulated by the BCKDH complex. In particular,
DBT belongs to the transacylase (E2) subunit and is a
key enzyme in amino acid metabolism. Each E2 subunit
consists of three independently functional domains: a
lipoyl-bearing domain located in the N-terminal portion,
an E1/E3-binding domain, and an inner-core domain at
the C-terminal portion, with the three domains tethered
by flexible linker regions [20]. The core domains of E2
subunit form a 24-meric scaffold, which is decoratedwith multiple copies of E1 and E3 attached through the
subunit-binding domain [19]. Although the basic en-
zyme activity of DBT is known, along with the protein
sequence and structure, the physiological functions in
amino acid metabolism under hypoxic stress are still
unknown. Although BCAAs are essential amino acids,
accumulation of BCAAs and their metabolites can be
toxic to cells; thus, hypoxia-induced BCAA accumula-
tion may promote kidney injury. The regulation of free
amino acid levels is an important factor in understand-
ing amino acid metabolism in acute hypoxia on tissues.
Here, we identified that the reinforced interaction be-
tween Prdx V and DBT in mouse kidney was inducible
by hypoxic stress. Additionally, we found that the enzyme
activity of DBT was increased in hypoxia versus normoxia.
Thus, we suggest that Prdx V may be an important molecule
for the regulation of DBTactivity through a direct interaction
under hypoxic stress.
Unlike other members of Prdx family, human Prdx V
does not contain a cysteine residue corresponding to the
second conserved cysteine residue of the 2-Cys subgroup
but possesses two additional cysteine residues (C73 and
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V belongs to the atypical 2-Cys family [15]. The atypical
2-Cys human Prdx have side chains for all Cys residues
(the peroxidatic Cys48, the resolving Cys152, and the
additional Cys73) characterized by the presence of a free
sulfhydryl group [21]. The peroxidatic residue Cys48 of
Prdx V is a highly conserved Cys residue in all peroxire-
doxins. This residue is located within the N-terminal
part of the α2-helix, twisted at Ala60, in the reduced
form, and lies in the positive charged active-site pocket
built by surrounding factors such as Arg128, Thr45, and
Val40 [15]. The resolving residue Cys152, located in the
loop between β7 and α6, is associated with the proposed
enzymatic mechanism of action of Prdx V. The proposed
enzymatic mechanism requires the formation of an
intramolecular disulfide bond between these two Cys
residues. The additional Cys, Cys73, is found in the C-
terminal part of the β4 stand of human Prdx V. How-
ever, this residue is not implicated in the enzymatic
mechanism, because its mutation does not modify the
activity [17]. It is thus surprising to find this Cys73 lo-
cated close to the peroxidatic Cys48, at the bottom of
the active-site pocket. Although the enzymatic mechan-
ism involving the cysteine residues is well established,
the physiological functions under specific stimulation
conditions are still unknown. Other investigators have
demonstrated that the catalytic cysteine of Prdx V has
an important role in cytoprotection effects via its anti-
oxidant activity [22]. Moreover, we recently reported a
novel function of the peroxidatic Cys48 as a specific
regulator of JAK2-Stat5 signaling triggered by lipopoly-
saccharide (LPS) [16]. Notably, it appeared that Prdx
V played a role in the regulation of IL-6 expression
through direct binding to Jak2 via its catalytic Cys48
residue, although this did not involve its peroxidase ac-
tivity. Consistent with that, our current data show that
hypoxia enhanced the direct interaction between Prdx V
and DBT, and this enhancement did require the catalytic
cysteine residue, Cys48, of Prdx V but not the other
cysteine residues (Cys73 and Cys152).
In summary, this study provides new findings of novel
Prdx V-interacting partners and showed alteration of
DBT enzymatic activity in the kidney under hypoxia,
which may be important for the kidney pathological
conditions, such as hypoxic stress. Further studies are
needed to explore the exact mechanism underlying Prdx
V-DBT protein interaction associated with kidney homeo-
stasis in chronic renal disease.
Conclusions
We have shown that Prdx V protein was interacting with
other proteins in mouse kidney responding to hypoxic
stress. One of interacting partner, DBT, showed enhanced
interaction with Prdx V under hypoxia. Interestingly, DBTenzymatic activity, known to be involved in mitochondrial
metabolism, was increased under hypoxia as well. In
addition, peroxidatic cysteine (Cys48) of Prdx V appeared
to be important for interaction with DBT. This study pro-
poses that Prdx V interacts with DBT and this interaction
may be associated with mitochondrial metabolism in
mouse kidney under hypoxia. Further functional analysis
is required to confirm this hypothesis and to elucidate the
underlying the role of Prdx V in biological mechanisms of
hypoxic stress-induced mitochondrial metabolism.
Methods
Hypoxic conditions, protein extraction and
immunoprecipitation
Mice (C57BL/6 J) were maintained under specific
pathogen-free (SPF) conditions. All animal-related
procedures were reviewed and approved under the
Animal Care Regulations (ACR) of Chonnam National
University (accession number: CNU IACUC-YB-2013-39).
Hypoxic stress was produced as described previously.
Briefly, mice were placed in a chamber designed to regu-
late the flow of N2 using a gas supply and the oxygen
concentration was maintained at 8 ± 0.5% O2 using an
oxygen controller (Proox Model 110; BioSpherix, NY,
USA). After 4 h of hypoxia, all mice (n = 10/each group,
8 weeks old) were induced with anesthesia under hyp-
oxic conditions, and the kidneys were rapidly collected
and frozen in liquid N2 [13].
Total protein extraction was performed according to
Yang et al. [13]. For immunoprecipitation assays, 500 μg
of total extracted proteins was incubated with 10 μL of
anti-Prdx V antibody at 4°C overnight. Then, immune
complexes were pulled down by incubating with protein
G agarose (Invitrogen, Carlsbad, CA) for 4 h at 4°C. The
immunoprecipitated complex was eluted with 60 mM
Tris–HCl (pH 6.8), 2.5% glycerol, 2% SDS, and 28.8 mM
β-mercaptoethanol, and then the eluted complex was
freeze-dried before being subjected to nano-UPLC-MS/
MS analysis for comparative proteomics.
Interactome analysis by nano-UPLC-MS/MS
For gel-assisted digestion, the dried pellet was resus-
pended in 50 μl of 6 M urea, 5 mM EDTA, and 2%
(w/v) SDS in 0.1 M tetra ethyl ammonium bicarbonate
(TEABC) and incubated at 37°C for 30 min for complete
dissolution. Proteins were reduced by adding 10 μL of
20 mM tris-2-carboxyethyl phosphine (TCEP) and alky-
lated followed by adding 20 μl of 20 mM iodoacetamide
(IAM) at room temperature for 30 min. To incorporate
proteins into a gel directly in the Eppendorf vial, 18.5 μl
of acrylamide/bisacrylamide solution (40%, v/v, 29:1),
2.5 μl of 10% (w/v) ammonium persulfate, and 1 μl of
100% TEMED was then applied to the protein solution.
The gel was cut into small pieces and then washed three
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(v/v) ACN. The dehydrated gel samples were then
digested with 15 μl trypsin (0.1 μg/μl) at 37°C for 18 hr.
Then the digested peptides were recovered twice with a
solution containing 50 mM ammonium bicarbonate,
50% acetonitrile, and 5% trifluoroacetic acid (TFA). The
resulting peptide extracts were pooled, dried in a vac-
uum centrifuge, and then dissolved in 0.1% formic acid
solution prior to MS or MS/MS analysis [14].
For nano-LC and tandem MS analysis, a nano-
ACQUITY Ultra Performance LC Chromatography™
equipped Synapt™ G2-S System (Waters Corporation,
MA, USA) used was previously described [23]. This step
was performed on a 75 μm× 250 mm nano-ACQUITY
UPLC 1.7 μm BEH300 C18 RP column and a 180 μm×
20 mm Symmetry C18 RP 5 μm enrichment column
using a nano-ACQUITY Ultra Performance LC Chroma-
tography™ System (Waters Corporation, MA, USA).
Trypsinized peptides (5 μL) were loaded onto the en-
richment column in mobile phase A (3% acetonitrile in
water with 0.1% formic acid). A step gradient was then
used at a flow rate of 300 nL/min. This included 3–40%
mobile phase B (97% acetonitrile in water with 0.1% for-
mic acid) run over 95 min, followed by 40–70% mobile
phase B run over 20 min, and finally a sharp increase to
80% B over 10 min. Sodium formate (1 μmol/min) was
used to calibrate the TOF analyzer in the range of m/z
50–2000, and [Glu1]-fibrinopeptide (m/z 785.8426) was
run at 600 nL/min for lock mass correction. During data
acquisition, the collision energies of low-energy mode
(MS) and high-energy mode (MSE) were set to 4 eV and
15–40 eV energy ramping, respectively. One cycle of
the MS and MSE modes of acquisition was performed
every 3.2 s. In each cycle, MS spectra were acquired
for 1.5 s with a 0.1 s interscan delay (m/z 300–1990),
and the MSE fragmentation (m/z 50–2000) data were
collected in triplicate.
The continuum LC-MSE data were processed and
searched using the IDENTITYE algorithm in PLGS
(ProteinLynx GlobalServer) version 2.5.2 (Waters Cor-
poration). The data acquired by alternating low and high
energy modes in the LC-MSE were automatically smoothed,
background subtracted, centered, deisotoped and charge
state reduced, after which alignment of the precursor and
fragmentation data were combined with retention time
tolerance (±0.05 min) using PLGS software.
Processed ions were mapped against the IPI mouse
database (version 3.87) using the following parameters:
peptide tolerance, 10 ppm; fragment tolerance, 0.05 Da;
missed cleavage, 1; and carbamidomethylation at C and
oxidation at methionine and cysteine. Peptide identifica-
tion was performed using the trypsin digestion rule with
one missed cleavage. As a result, protein identification
was completed with arrangement of at least two peptides.All proteins identified on the basis the IDENTITYE
algorithm are in keeping with > 95% probability. The false
positive rate for protein identification was set at 5% in the
databank search query option, based on the automatically
generated reversed database in PLGS 2.5.2. Protein identi-
fication was also based on the assignment of at least two
peptides comprised of seven fragments or more [23].
Cell culture and transfection
HEK293 cells were cultured in Eagle’s Minimal Essential
Medium (MEM) supplemented with 10% (v/v) fetal bo-
vine serum (FBS), 1% glutamine, 100 mg/ml streptomycin,
and 100 units/ml penicillin at 37°C in a humidified 5%
CO2 atmosphere. Lipofectamine 2000 (Invitrogen) re-
agents were used for transfection according to the manu-
facturer’s instructions. At 48 hr after transfection, cells for
hypoxic treatment were moved to a hypoxic incubator,
and exposed to hypoxic stress, 1 ± 0.2% O2, for 6 h.
Plasmid construction
Mouse Prdx V expression (WT, C48S, C73S, C152S, and
C48/152S) vectors with N-terminal HA-tags were con-
structed as in our previous study [24]. The full-length
DBT cDNA was purchased from Korea Human Gene
Bank (clone ID: hMU001786). The human DBT was sub-
cloned into the pCMV-Myc-N vector with N-terminal
myc-tag (Clontech Laboratories, CA, USA).
DBT enzymatic activity
To measure the enzymatic activity of DBT, mitochon-
drial proteins from mouse hypoxic kidney (n = 10/each
group) were isolated using the Qproteome Mitochondria
Isolation Kit (Qiagen Sciences, Valencia, CA) according
to the manufacturer’s instructions. Using isolated mito-
chondrial proteins, branched-chain α-keto acid dehydro-
genase (BCKDH) complex activity was determined
spectrophotometrically at 37°C by measuring the rate
of NADH generation from NAD+ in the presence of
substrate for BCKDH complex as described previously
[25]. The reaction was started by adding the substrate
and the change in the absorbance at 340 nm was re-
corded for 30 min. The BCKDH specific activity was
expressed in mU/mg of mitochondrial protein: 1 mU
was defined as the amount of enzyme that catalyzed
the formation of NADH per min at 37°C.
Confocal fluorescence microscopy
HEK293 cells grown on poly L-lysine-treated glass cov-
erslips were transiently transfected with Prdx V- and
DBT-expressing vectors and then subjected to hypoxic
stress, as described above. After hypoxic treatment, cells
were fixed with 4% paraformaldehyde, permeabilized
with 0.1% Triton X-100 and stained with anti-HA and
anti-myc antibodies, followed by Alexa fluor555- and
Ahn et al. Proteome Science  (2015) 13:4 Page 9 of 9Alexa fluor488-conjugated second antibodies. Then, cells
were washed and mounted, and examined using a LSM
710 laser scanning confocal microscope (Carl Zeiss, Jena,
Germany). Images were taken with a 63× objective at
identical imaging settings.
Additional file
Additional file 1: Figure S1. Coprecipitation of endogenous Prdx V with
Pccb, Rab43, and Alb proteins. Mouse kidney lysates were extracted under
normoxic (N) and hypoxic (H) conditions, as indicated. The extracted kidney
proteins were purified using Rab43, Pccb, or Alb antibodies, as indicated,
and probed with Prdx V antibody to detect the interaction with Prdx V.
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